Israel Englander Actinium Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 67,411 shares of ATNM stock, worth $549,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,411Holding current value
$549,399% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding ATNM
# of Institutions
72Shares Held
6.65MCall Options Held
369KPut Options Held
148K-
Black Rock Inc. New York, NY1.71MShares$13.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$11.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA596KShares$4.86 Million0.0% of portfolio
-
State Street Corp Boston, MA551KShares$4.49 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL231KShares$1.88 Million0.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $205M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...